2m 2m 2m 2m 2m 2m 2m
NEURAXIS (NRXS)
NYSE
$7.00-$0.008 (-0.11%)
Price as of Jun 03, 2026 4:32 PM EDT- $91.8MMarket Cap
- 153.07%1-Year Change
- BiotechnologyIndustry
NEURAXIS (NRXS)
$7.00-$0.008 (-0.11%)
NRXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.01 | ||
Change | -$0.33 (-4.50%) | ||
Open | $7.18 | ||
High | $7.27 | ||
Low | $6.80 | ||
Previous Close | $7.34 | ||
Volume | 239,445 | ||
30-Day Average Volume | 172,537 | ||
1-Week Change | 0.14% | ||
1-Month Change | -13.24% | ||
1-Year Change | 153.07% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.4M | ||
Total Assets | $8.7M | ||
Market Cap | $91.8M | ||
Enterprise Value | $85.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.6M | ||
Net Income | -$2.0M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$1.9M | ||
EBITDA | -$1.9M | ||
Net Working Capital | $5.3M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | 53 | ||
P/B | 16 | ||
P/E | -41 | ||
PEG | -30 | ||
Price/Free Cash Flow | -75 | ||
Price/Operating Cash Flow | -75 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue